Oct-Dec, 2011 - Indian Journal of Pharmacy Practice
Oct-Dec, 2011 - Indian Journal of Pharmacy Practice Oct-Dec, 2011 - Indian Journal of Pharmacy Practice
Daxesh M P - Combating Antimicrobial Resistance: 2011 is the year of “No action today, No cure tomorrowIndicators to field test various objectives such asantimicrobial prescribing practices, comparativeperformance between hospitals or prescribers, monitoringperformance and orienting supervision, and assessing32changes resulting from interventions. Field Trials of hospitalantimicrobial indicators were done in six hospitals in Uganda42and Ghana. A baseline survey on antimicrobial drug use,AMR and its containment has been done in Ethiopia with thesupport of the Drug Administration and Control Authority ofEthiopia in collaboration with Management Sciences for[43]Health. Developing countries such as India and SouthAfrica have to conduct more operational research in thesecritical areas of AMR in order to combat the growing menaceto public health because effective antibiotics are becominguseless due to increased misuse.REFERENCES1. World Health Day 2011. COMBAT ANTIMICROBIALRESISTANCE. No Action Today, No Cure Tomorrow. Availablefrom: www.who.int/world-health-day/2011 Accessed on 18September 2011.2. WHO global strategy for containment of antimicrobialr e s i s t a n c e . 2 0 0 1 A v a i l a b l e f r o m :h t t p : / / w w w . w h o . i n t / d r u g r e s i s t a n c e/WHO_Global_Strategy_English.pdf Accessed on 10September 2011.3. Antimicrobial resistance [online]. Available from:http://www.who.int/ mediacentre/factsheets/fs194/en/Accessed on 12 September 2011.4.. Avorn JL, Barrett JF, Davey PG, et al. AntimicrobialResistance: synthesis of Recommendations of Expert PolicyG r o u p s . 2 0 0 1 . A v a i l a b l e f r o m :http://whqlibdoc.who.int/hq/2001/WHO_CDS_CSR_DRS_2001.10.pdf Accessed on 11 September 2011.5. WHO workshop on containment of antimicrobial resistance inE u r o p e 2 0 0 4 . A v a i l a b l e f r o m :http://www.who.int/drugresistance/infosharing/AMR_WS_WERNIGERODE_REPORT_EURO.pdf Accessed on 15September 2011.6.Ham Rianne van den, Bero L, Laing R. Selection of EssentialMedicines, The World Medicines Situation 2011. Availablefrom: http://apps.who.int/medicinedocs/documents/s18770en/s18770en.pdfAccessed on 9 September 2011.7. WHO. Essential Medicines (Online) Available from:http://www.who.int/mediacentre/factsheets/fs325/en/index.html Accessed on 27 September 2011.8. Fifty-First World Health Assembly. Emerging and othercommunicable diseases: Antimicrobial Resistance. WorldHealth Organization, Geneva 1998 May. Available from:http://apps.who.int/medicinedocs/documents/s16334e/s16334e.pdf Accessed on 2 August 2011.9. National Pharmaceutical Policy, 2006. Available from:http://www.drugscontrol.org/draftNPP2006.pdf Accessed on18 September 2011.10. National Drug Policy for India, 1986. Available from:http://nppaindia.nic.in/drug_pol86/txt1.html Accessed on 29August 2011.11. National List of Essential Medicines of India 2011. Availablefrom: http://cdsco.nic.in/National%20List%20of%20Essential%20Medicine-%20final%20copy.pdf Accessed on27 August 2011.12. National Drug Policy for South Africa 1996. Available from:http://apps.who.int/medicinedocs/documents/s17744en/s17744en.pdf Accessed on 18 August 2011.13. Standard Treatment Guidelines and Essential Medicines List2008, Essential Drug Programme, South Africa. Availablefrom: http://www.kznhealth.gov.za/edlphc2008.pdf Accessedon 9 August 2011.14. WHO Scientific working group on monitoring andmanagement of bacterial resistance to antimicrobial agents1994, Geneva.15. Xiao Y-Hong, Giske CG, Wei Ze-Qing, Shen P, Heddini A, Li L-Juan. Epidemiology and characteristics of antimicrobialresistance in China [Internet]. Drug Resistance Updates.2011: 1-15. Accessed on 3 August 2011.16. Sixtieth World Health Assembly. Progress reports on technicaland health matters. World Health Organization. 2007 April 5.Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA60/A60_28-en.pdf Accessed on 2 August 2011.17. Diazgranados CA, Cardo DM, McGowan JE. Antimicrobialresistance: international control strategies, with a focus onlimited-resource settings. [Internet]. International journal ofantimicrobial agents. 2008 July 32(1): 1-9. Available from:http://www.ncbi.nlm.nih.gov/pubmed/18550343 Accessed on2 August 2011.18. Eggleston K, Zhang R, Zeckhauser RJ. The Global Challengeof Antimicrobial Resistance: Insights from Economic Analysis.International Journal of Environmental Research and PublicHealth. 2010 August 9: 3141-3149.Indian Journal of Pharmacy Practice Volume 4 Issue 4 Oct - Dec, 2011 6
Daxesh M P - Combating Antimicrobial Resistance: 2011 is the year of “No action today, No cure tomorrow19. Cosgrove SE. The Relationship between AntimicrobialResistance and Patient Outcomes: Mortality, Length ofHospital Stay, and Health Care Costs. Clinical InfectiousDiseases. 2006; 21287(Suppl 2):82-89.20. Coast J, Smith RD, Millar MR. An Economic Perspective onPolicy to Reduce Antimicrobial Resistance. Social Scienceand Medicine. 1998; 46(1): 29-38.21. Kunin CM, Lipton HL, Tupasi T, Sacks T, Scheckler E W,Jivani A, et al. Social, Behavioural, and Practical FactorsAffecting Antibiotic Use Worldwide : Report of Task Force 4.Reviews of Infectious Diseases. 1987 May-June; 9(3): S270-S285. Available from: http://www.jstor.org/stable/4454153Accessed on 25 August 2011.22. WHO European Region (Online) Available from:h t t p : / / w w w. e u r o . w h o . i n t / e n / w h a t - w e - d o / h e a l t h -topics/disease-prevention/antimicrobial-resistance/antibioticresistanceAccessed on 25 August 2011.23. Nelson N, Joshi M, Kirika R. Antimicrobial Resistance: TheNeed for Action in the East, Central and Southern AfricaR e g i o n . 2 0 0 9 . A v a i l a b l e f r o m :http://pdf.usaid.gov/pdf_docs/PNADP643.pdf Accessed on25 August 2011.24. Bartlett JG. The Potential Disaster of Extensively DrugResistance Tuberculosis. Centre for Biosecurity of UPMCClinicians Biosecurity News Analysis of Advances andChallenges in Clinical Biosecurity. 2006 November. Availablef r o m : h t t p : / / w w w . u p m c -cbn.org/report_archive/2006/cbnreport_111006.htmlAccessed on 27 August 2011.25. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P,O'Brien TF, et al. Antimicrobial resistance in developingcountries. Part I: recent trends and current status. [Internet].The Lancet infectious diseases. 2005 Aug; 5(8):481-93.Available from: http://www.ncbi.nlm.nih.gov/pubmed/16048717 Accessed on 29 August 2011.26. Canadian Committee on Antibiotic Resistance. Antimicrobialresistance: A Deadly Burden No Country Can Afford to Ignore.Canada Communicable Disease Report. 2003 September;29(18). Accessed on 1 October 2011.27. Mason PR, Gwanzura L, Latif AS, Marowa E, et al.Antimicrobial resistance in gonococci isolated from patientsand from commercial sex workers in Harare, Zimbabwe.International Journal of Antimicrobial Agents. 1998 9; 175-179. Accessed on 1 October 2011.28. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F,Balakrishnan R, et al. Emergence of a new antibioticresistance mechanism in India, Pakistan, and the UK: amolecular, biological, and epidemiological study [Internet].The Lancet Infectious Diseases. 2010 Aug; 597-602. [cited 11A u g 2 0 1 0 ] A v a i l a b l e f r o m :http://linkinghub.elsevier.com/retrieve/pii/S1473309910701432 Accessed on 3 March 2011.29. Yeung S. et al. Antimalarials Drug Resistance, ArtemisininbasedCombination Therapy, and the Contribution ofModeling to Elucidating Policy Choices. The American Societyof Tropical Medicine and Hygiene. 2004; 71 (Suppl. 2): 179-186.30. Dancer SJ 2005. “The Real Cost of MRSA”. In AntibioticPolicies: Theory and Practice. Ed. Gould and van der Meer.Kluwer Academic/Plenum Publishers, New York. Quoted inNelson N, Joshi M, Kirika R. 2009. Antimicrobial Resistance:The Need for Action in the East, Central and Southern AfricaRegion.31. French GL. The continuing crisis in antibiotic resistance[Internet]. International Journal of Antimicrobial Agents. 2010;36S3-S7. Available from: http://dx.doi.org/10.1016/S0924-8579(10)70003-0 Accessed on 4 August 2011.32. World Health Organization (WHO) 2008. How to InvestigateAntimicrobial Use in Hospitals: Selected Indicators. Publishedfor the U.S. Agency for International Development. Availablef r o m : h t t p : / / w w w . m s h . o r g / p r o j e c t s / s p s / S P S -Documents/upload/Indicator-based-Study-on-Hospital-Antimicrobial Use_Manual_Final.pdf Accessed on 4 August2011.33. Hsueh Po-Ren. World Health Day 2011 — AntimicrobialResistance: No Action Today, No Cure Tomorrow [Internet].Journal of the Formosan Medical Association. 2011;1 1 0 ( 4 ) : 2 1 3 - 2 1 4 . A v a i l a b l e f r o m :http://www.sciencedirect.com/science/article/pii/S0929664611600326 Accessed on 4 August 2011.34. WHO. Antimicrobial resistance and its global spread, 2011.Available at: http://www.who.int/world-health-day/en/index.html Accessed on 2 August 2011.35. WHO. WHO urges countries to take measures to combata n t i m i c r o b i a l r e s i s t a n c e , 2 0 1 0 . A v a i l a b l e a t :http://www.who.int/mediacentre/news/releases/2010/amr_20100820/en/ Accessed on 2 August 2011.36. WHO. Combating Antimicrobial Resistance: Experiencesfrom the Field. 2011. Available from: http://www.who.int/worldhealth-day/2011/tested_interventions.pdfAccessed on 4August 2011.Indian Journal of Pharmacy Practice Volume 4 Issue 4 Oct - Dec, 2011 7
- Page 1 and 2: Indian Journal of Pharmacy Practice
- Page 3 and 4: Dear ReadersIndian Journal of Pharm
- Page 5 and 6: Daxesh M P - Combating Antimicrobia
- Page 7: Daxesh M P - Combating Antimicrobia
- Page 11 and 12: Indian Journal of Pharmacy Practice
- Page 13 and 14: J. Chang - India's Progress towards
- Page 15 and 16: J. Chang - India's Progress towards
- Page 17 and 18: Shobha C - Poison Information Cente
- Page 19 and 20: Shobha C - Poison Information Cente
- Page 21 and 22: Shobha C - Poison Information Cente
- Page 23 and 24: Indian Journal of Pharmacy Practice
- Page 25 and 26: Anantha Naik N -Health Related Qual
- Page 27 and 28: Anantha Naik N -Health Related Qual
- Page 29 and 30: Anantha Naik N -Health Related Qual
- Page 31 and 32: Indian Journal of Pharmacy Practice
- Page 33 and 34: Amrita P - Scenario of Pharmacovigi
- Page 36 and 37: Amrita P - Scenario of Pharmacovigi
- Page 38 and 39: Amrita P - Scenario of Pharmacovigi
- Page 40 and 41: Amrita P - Scenario of Pharmacovigi
- Page 42 and 43: Satyanarayana V - Evaluation of the
- Page 44 and 45: Satyanarayana V - Evaluation of the
- Page 46 and 47: Satyanarayana V - Evaluation of the
- Page 48 and 49: Satyanarayana V - Evaluation of the
- Page 50 and 51: Satyanarayana V - Evaluation of the
- Page 52 and 53: Dinesh KU - Evaluation of the Impac
- Page 54 and 55: Dinesh KU - Evaluation of the Impac
- Page 56 and 57: Dinesh KU - Evaluation of the Impac
Daxesh M P - Combating Antimicrobial Resistance: <strong>2011</strong> is the year <strong>of</strong> “No action today, No cure tomorrowIndicators to field test various objectives such asantimicrobial prescribing practices, comparativeperformance between hospitals or prescribers, monitoringperformance and orienting supervision, and assessing32changes resulting from interventions. Field Trials <strong>of</strong> hospitalantimicrobial indicators were done in six hospitals in Uganda42and Ghana. A baseline survey on antimicrobial drug use,AMR and its containment has been done in Ethiopia with thesupport <strong>of</strong> the Drug Administration and Control Authority <strong>of</strong>Ethiopia in collaboration with Management Sciences for[43]Health. Developing countries such as India and SouthAfrica have to conduct more operational research in thesecritical areas <strong>of</strong> AMR in order to combat the growing menaceto public health because effective antibiotics are becominguseless due to increased misuse.REFERENCES1. World Health Day <strong>2011</strong>. COMBAT ANTIMICROBIALRESISTANCE. No Action Today, No Cure Tomorrow. Availablefrom: www.who.int/world-health-day/<strong>2011</strong> Accessed on 18September <strong>2011</strong>.2. WHO global strategy for containment <strong>of</strong> antimicrobialr e s i s t a n c e . 2 0 0 1 A v a i l a b l e f r o m :h t t p : / / w w w . w h o . i n t / d r u g r e s i s t a n c e/WHO_Global_Strategy_English.pdf Accessed on 10September <strong>2011</strong>.3. Antimicrobial resistance [online]. Available from:http://www.who.int/ mediacentre/factsheets/fs194/en/Accessed on 12 September <strong>2011</strong>.4.. Avorn JL, Barrett JF, Davey PG, et al. AntimicrobialResistance: synthesis <strong>of</strong> Recommendations <strong>of</strong> Expert PolicyG r o u p s . 2 0 0 1 . A v a i l a b l e f r o m :http://whqlibdoc.who.int/hq/2001/WHO_CDS_CSR_DRS_2001.10.pdf Accessed on 11 September <strong>2011</strong>.5. WHO workshop on containment <strong>of</strong> antimicrobial resistance inE u r o p e 2 0 0 4 . A v a i l a b l e f r o m :http://www.who.int/drugresistance/infosharing/AMR_WS_WERNIGERODE_REPORT_EURO.pdf Accessed on 15September <strong>2011</strong>.6.Ham Rianne van den, Bero L, Laing R. Selection <strong>of</strong> EssentialMedicines, The World Medicines Situation <strong>2011</strong>. Availablefrom: http://apps.who.int/medicinedocs/documents/s18770en/s18770en.pdfAccessed on 9 September <strong>2011</strong>.7. WHO. Essential Medicines (Online) Available from:http://www.who.int/mediacentre/factsheets/fs325/en/index.html Accessed on 27 September <strong>2011</strong>.8. Fifty-First World Health Assembly. Emerging and othercommunicable diseases: Antimicrobial Resistance. WorldHealth Organization, Geneva 1998 May. Available from:http://apps.who.int/medicinedocs/documents/s16334e/s16334e.pdf Accessed on 2 August <strong>2011</strong>.9. National Pharmaceutical Policy, 2006. Available from:http://www.drugscontrol.org/draftNPP2006.pdf Accessed on18 September <strong>2011</strong>.10. National Drug Policy for India, 1986. Available from:http://nppaindia.nic.in/drug_pol86/txt1.html Accessed on 29August <strong>2011</strong>.11. National List <strong>of</strong> Essential Medicines <strong>of</strong> India <strong>2011</strong>. Availablefrom: http://cdsco.nic.in/National%20List%20<strong>of</strong>%20Essential%20Medicine-%20final%20copy.pdf Accessed on27 August <strong>2011</strong>.12. National Drug Policy for South Africa 1996. Available from:http://apps.who.int/medicinedocs/documents/s17744en/s17744en.pdf Accessed on 18 August <strong>2011</strong>.13. Standard Treatment Guidelines and Essential Medicines List2008, Essential Drug Programme, South Africa. Availablefrom: http://www.kznhealth.gov.za/edlphc2008.pdf Accessedon 9 August <strong>2011</strong>.14. WHO Scientific working group on monitoring andmanagement <strong>of</strong> bacterial resistance to antimicrobial agents1994, Geneva.15. Xiao Y-Hong, Giske CG, Wei Ze-Qing, Shen P, Heddini A, Li L-Juan. Epidemiology and characteristics <strong>of</strong> antimicrobialresistance in China [Internet]. Drug Resistance Updates.<strong>2011</strong>: 1-15. Accessed on 3 August <strong>2011</strong>.16. Sixtieth World Health Assembly. Progress reports on technicaland health matters. World Health Organization. 2007 April 5.Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA60/A60_28-en.pdf Accessed on 2 August <strong>2011</strong>.17. Diazgranados CA, Cardo DM, McGowan JE. Antimicrobialresistance: international control strategies, with a focus onlimited-resource settings. [Internet]. International journal <strong>of</strong>antimicrobial agents. 2008 July 32(1): 1-9. Available from:http://www.ncbi.nlm.nih.gov/pubmed/18550343 Accessed on2 August <strong>2011</strong>.18. Eggleston K, Zhang R, Zeckhauser RJ. The Global Challenge<strong>of</strong> Antimicrobial Resistance: Insights from Economic Analysis.International <strong>Journal</strong> <strong>of</strong> Environmental Research and PublicHealth. 2010 August 9: 3141-3149.<strong>Indian</strong> <strong>Journal</strong> <strong>of</strong> <strong>Pharmacy</strong> <strong>Practice</strong> Volume 4 Issue 4 <strong>Oct</strong> - <strong>Dec</strong>, <strong>2011</strong> 6
Change language